Sensus Healthcare, Inc. Research and Development Expense
Sensus Healthcare, Inc. (SRTS) reported Research and Development Expense of $1.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Sensus Healthcare, Inc. research and development expense for the quarter ending 2026-06-30 was $1.11M, a 24.61% decline year-over-year.
- Sensus Healthcare, Inc. research and development expense for the quarter ending 2026-03-31 was $1.59M, a 38.99% decline year-over-year.
- Sensus Healthcare, Inc. research and development expense for the quarter ending 2025-12-31 was $1.88M, a 20.56% increase year-over-year.
- Sensus Healthcare, Inc. research and development expense for the quarter ending 2025-09-30 was $1.82M, a 110.78% increase year-over-year.
- Sensus Healthcare, Inc. research and development expense for fiscal 2025 was $7.78M, a 84.49% increase from fiscal 2024.
- Sensus Healthcare, Inc. research and development expense for fiscal 2024 was $4.22M, a 14.63% increase from fiscal 2023.
- Sensus Healthcare, Inc. research and development expense for fiscal 2023 was $3.68M, a 6.30% increase from fiscal 2022.
- Sensus Healthcare, Inc. research and development expense for fiscal 2022 was $3.46M, a 0.70% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.11M 10-Q · filed 2026-08-14 | $2.70M 10-Q · filed 2026-08-14 | $4.58M derived: sum of 3 quarters · filed 2026-08-14 | $6.40M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $1.59M 10-Q · filed 2026-05-13 | $3.47M derived: sum of 2 quarters · filed 2026-05-13 | $5.29M derived: sum of 3 quarters · filed 2026-05-13 | $6.76M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $3.70M derived: sum of 2 quarters · filed 2026-03-04 | $5.17M derived: sum of 3 quarters · filed 2026-08-14 | $7.78M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $1.82M 10-Q · filed 2025-11-12 | $3.29M derived: sum of 2 quarters · filed 2026-08-14 | $5.90M 10-Q · filed 2025-11-12 | $7.46M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.47M 10-Q · filed 2026-08-14 | $4.08M 10-Q · filed 2026-08-14 | $5.64M derived: sum of 3 quarters · filed 2026-08-14 | $6.50M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $2.61M 10-Q · filed 2026-05-13 | $4.17M derived: sum of 2 quarters · filed 2026-05-13 | $5.03M derived: sum of 3 quarters · filed 2026-05-13 | $5.90M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.42M derived: sum of 2 quarters · filed 2026-03-04 | $3.29M derived: sum of 3 quarters · filed 2026-03-04 | $4.22M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $863.00K 10-Q · filed 2025-11-12 | $1.73M derived: sum of 2 quarters · filed 2025-11-12 | $2.65M 10-Q · filed 2025-11-12 | $3.33M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $866.00K 10-Q · filed 2025-08-12 | $1.79M 10-Q · filed 2025-08-12 | $2.47M derived: sum of 3 quarters · filed 2025-08-12 | $3.55M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $926.00K 10-Q · filed 2025-05-15 | $1.60M derived: sum of 2 quarters · filed 2025-05-15 | $2.69M derived: sum of 3 quarters · filed 2025-05-15 | $3.51M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $677.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $1.76M derived: sum of 2 quarters · filed 2025-03-05 | $2.58M derived: sum of 3 quarters · filed 2025-03-05 | $3.68M 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $1.08M 10-Q · filed 2024-11-14 | $1.91M derived: sum of 2 quarters · filed 2024-11-14 | $3.00M 10-Q · filed 2024-11-14 | $4.16M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $822.00K 10-Q · filed 2024-08-13 | $1.92M 10-Q · filed 2024-08-13 | $3.08M derived: sum of 3 quarters · filed 2024-08-13 | $3.82M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $1.10M 10-Q · filed 2024-05-10 | $2.26M derived: sum of 2 quarters · filed 2024-05-10 | $3.00M derived: sum of 3 quarters · filed 2024-05-10 | $3.83M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.90M derived: sum of 2 quarters · filed 2024-03-15 | $2.73M derived: sum of 3 quarters · filed 2024-03-15 | $3.46M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $746.00K 10-Q · filed 2023-11-13 | $1.57M derived: sum of 2 quarters · filed 2023-11-13 | $2.30M 10-Q · filed 2023-11-13 | $3.41M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $827.00K 10-Q · filed 2023-08-11 | $1.56M 10-Q · filed 2023-08-11 | $2.66M derived: sum of 3 quarters · filed 2023-08-11 | $3.40M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $728.00K 10-Q · filed 2023-05-12 | $1.83M derived: sum of 2 quarters · filed 2023-05-12 | $2.58M derived: sum of 3 quarters · filed 2023-05-12 | $3.50M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.85M derived: sum of 2 quarters · filed 2023-03-23 | $2.77M derived: sum of 3 quarters · filed 2023-03-23 | $3.44M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $744.00K 10-Q · filed 2022-11-10 | $1.67M derived: sum of 2 quarters · filed 2022-11-10 | $2.33M 10-Q · filed 2022-11-10 | $3.17M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $925.00K 10-Q · filed 2022-08-12 | $1.59M 10-Q · filed 2022-08-12 | $2.43M derived: sum of 3 quarters · filed 2022-08-12 | $3.37M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $661.00K 10-Q · filed 2022-05-12 | $1.50M derived: sum of 2 quarters · filed 2022-05-12 | $2.44M derived: sum of 3 quarters · filed 2022-05-12 | $3.59M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $1.78M derived: sum of 2 quarters · filed 2022-03-25 | $2.93M derived: sum of 3 quarters · filed 2022-03-25 | $4.16M 10-K · filed 2022-03-25 | $4.16M 10-K · filed 2021-03-05 | |||
| 2020-09-30 | $941.00K 10-Q · filed 2021-11-10 | $941.74K 10-Q · filed 2020-11-10 | $2.09M derived: sum of 2 quarters · filed 2021-11-10 | $3.31M 10-Q · filed 2021-11-10 | $3.32M 10-Q · filed 2020-11-10 | $4.26M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $1.15M 10-Q · filed 2021-08-13 | $1.15M 10-Q · filed 2020-08-10 | $2.37M 10-Q · filed 2021-08-13 | $2.37M 10-Q · filed 2020-08-10 | $3.32M derived: sum of 3 quarters · filed 2021-08-13 | $4.89M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $1.23M 10-Q · filed 2021-05-14 | $1.23M 10-Q · filed 2020-05-11 | $2.17M derived: sum of 2 quarters · filed 2021-05-14 | $3.74M derived: sum of 3 quarters · filed 2021-05-14 | $5.68M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $949.67K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $2.52M derived: sum of 2 quarters · filed 2021-03-05 | $4.45M derived: sum of 3 quarters · filed 2021-03-05 | $6.42M 10-K · filed 2021-03-05 | ||||
| 2019-09-30 | $1.57M 10-Q · filed 2020-11-10 | $3.50M derived: sum of 2 quarters · filed 2020-11-10 | $5.47M 10-Q · filed 2020-11-10 | $6.95M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $1.93M 10-Q · filed 2020-08-10 | $3.90M 10-Q · filed 2020-08-10 | $5.38M derived: sum of 3 quarters · filed 2020-08-10 | $7.10M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $1.97M 10-Q · filed 2020-05-11 | $3.45M derived: sum of 2 quarters · filed 2020-05-11 | $5.16M derived: sum of 3 quarters · filed 2020-05-11 | $6.73M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $3.20M derived: sum of 2 quarters · filed 2020-03-06 | $4.76M derived: sum of 3 quarters · filed 2020-03-06 | $6.26M 10-K · filed 2020-03-06 | ||||
| 2018-09-30 | $1.71M 10-Q · filed 2019-11-08 | $3.28M derived: sum of 2 quarters · filed 2019-11-08 | $4.78M 10-Q · filed 2019-11-08 | $6.47M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $1.57M 10-Q · filed 2019-08-12 | $3.06M 10-Q · filed 2019-08-12 | $4.76M derived: sum of 3 quarters · filed 2019-08-12 | $6.26M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $1.50M 10-Q · filed 2019-05-14 | $3.19M derived: sum of 2 quarters · filed 2019-05-14 | $4.69M derived: sum of 3 quarters · filed 2019-05-14 | $5.85M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $3.20M derived: sum of 2 quarters · filed 2019-03-15 | $4.36M derived: sum of 3 quarters · filed 2019-03-15 | $5.49M 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | $1.50M 10-Q · filed 2018-11-06 | $2.66M derived: sum of 2 quarters · filed 2018-11-06 | $3.80M 10-Q · filed 2018-11-06 | $4.52M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-06-30 | $1.16M 10-Q · filed 2018-08-14 | $2.29M 10-Q · filed 2018-08-14 | $3.02M derived: sum of 3 quarters · filed 2018-08-14 | $3.41M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $1.14M 10-Q · filed 2018-05-08 | $1.86M derived: sum of 2 quarters · filed 2018-05-08 | $2.25M derived: sum of 3 quarters · filed 2018-05-08 | $2.67M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $727.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $1.12M derived: sum of 2 quarters · filed 2018-02-15 | $1.53M derived: sum of 3 quarters · filed 2018-02-15 | $1.82M 10-K · filed 2018-02-15 | ||||
| 2016-09-30 | $389.76K 10-Q · filed 2017-11-06 | $803.38K derived: sum of 2 quarters · filed 2017-11-06 | $1.10M 10-Q · filed 2017-11-06 | $1.43M derived: sum of 4 quarters · filed 2017-11-06 | ||||
| 2016-06-30 | $413.63K 10-Q · filed 2017-08-04 | $707.03K 10-Q · filed 2017-08-04 | $1.04M derived: sum of 3 quarters · filed 2017-08-04 | $1.40M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $293.40K 10-Q · filed 2017-05-09 | $627.71K derived: sum of 2 quarters · filed 2017-05-09 | $986.20K derived: sum of 3 quarters · filed 2017-05-09 | $1.32M derived: sum of 4 quarters · filed 2017-05-09 | ||||
| 2015-12-31 | $334.31K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $692.80K derived: sum of 2 quarters · filed 2017-03-10 | $1.03M derived: sum of 3 quarters · filed 2017-03-10 | $1.47M 10-K · filed 2017-03-10 | ||||
| 2015-09-30 | $358.49K 10-Q · filed 2016-11-07 | $692.61K derived: sum of 2 quarters · filed 2016-11-07 | $1.13M 10-Q · filed 2016-11-07 | |||||
| 2015-06-30 | $334.12K 10-Q · filed 2016-08-15 | $773.93K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |